(PRWEB) March 07, 2014
New report, "United States Orthobiologics Market Outlook to 2020", provides key market data on the United States Orthobiologics market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories Bone Graft Substitutes, Viscosupplementation, Bone Allografts and Bone Growth Stimulators.
Browse Full Report With TOC: http://www.marketresearchreports.biz/analysis-details/united-states-orthobiologics-market-outlook-to-2020
The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Orthobiologics market wherever available.
The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.
The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.
Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).
To Get Download Full Report With TOC: http://www.marketresearchreports.biz/sample/sample/190305
Market size for Orthobiologics market categories Bone Graft Substitutes, Viscosupplementation, Bone Allografts and Bone Growth Stimulators.
Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2005 to 2012 and forecast to 2020.
2012 company shares and distribution shares data for each of the market categories.
Global corporate-level profiles of key companies operating within the United States Orthobiologics market.
Reasons to buy
Develop business strategies by identifying the key market segments poised for strong growth in the future.
Develop market-entry and market expansion strategies.
Design competition strategies by identifying who-stands-where in the market.
Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
Table of Contents
1 Table of Contents
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
To Read Complete Report With TOC: http://www.marketresearchreports.biz/analysis/190305
2 Introduction 10
2.1 What Is This Report About?
2.2 Orthobiologics Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Orthobiologics Market, United States
3.1 Orthobiologics Market, United States, Revenue ($m), 2005-2012
3.2 Orthobiologics Market, United States, Revenue ($m), 2012-2020
3.2.1 Bone Graft Substitutes Market, United States, Revenue ($m), by Segment, 2005-2012
3.2.2 Bone Graft Substitutes Market, United States, Revenue ($m), by Segment, 2012-2020
3.3 Orthobiologics Market, United States, Volume (Units), 2005-2012 20
4 Overview of Key Companies in United States Orthobiologics Market
4.1 Medtronic, Inc.
4.1.1 Company Overview
4.2 DePuy Companies
4.2.1 Company Overview
4.3.1 Company Overview
4.4 Globus Medical, Inc.
4.4.1 Company Overview
4.5 NuVasive, Inc.
Global And China Industrial Enzyme Industry Report, 2014-2016
In 2007-2013, the global industrial enzyme market size grew at the CAGR of 5.7%, reaching USD4.04 billion in 2013, 1.4 times that in 2007. The global industrial enzyme market is monopolized by a small number of large enterprises with R & D and market dominance. Novozymes, the world's largest enzyme preparation R & D and manufacturing company, possesses more than 45% share in the global market always.
In 2013, China’s industrial enzyme output jumped by 8% year on year to 1.0588 million tons. At present, enzyme preparation is used widely in brewing, washing and other industries; it shows potentials in starch processing, feedstuff and other sectors; its application in papermaking, textile and others just arises, but with a promising prospect. In 2013, Novozymes and other world-renowned companies aggressively expanded the Chinese market; VTR, Youteer and other local companies also raised capacity vigorously.
To Get Download Full Report With TOC: http://www.marketresearchreports.biz/sample/sample/189184
In 2008-2013, the gross margin of the global and Chinese major enzyme preparation enterprises remained at 30%-50%. Compared with well-known international companies, Chinese enterprises are backward in technology and R & D; their products are mainly used in the feedstuff field, while partly in textile, papermaking and other industries, reflecting weak market competitiveness.
Table of Content
1 Overview of Industrial Enzyme
2 Development of Global Industrial Enzyme Industry
2.1 Market Size
2.2 Competition Pattern
2.3 Demand Structure
3 Development of China Industrial Enzyme Industry
3.3 Import and Export
3.4 Competition Pattern
4 Impact of Downstream Sectors on China Enzyme Preparation Industry
4.1 Food Industry
4.1.1 Starch Processing
4.2 Feedstuff Industry
4.3 Brewing Industry
China Reactive Power Compensation Device Industry Report , 2013-2015
Stimulated by the continuous improvement of China’s industrial and residential electricity demand, increasing investment in power grid, and accelerated development of reactive power compensation industry, the market scale of reactive power compensation device industry has been expanding.
Currently the most widely used reactive power compensation devices are still the traditional reactive power compensation devices and Static Var Compensator (SVC). The traditional reactive power compensation devices mainly include high voltage shunt capacitor bank reactive power compensation devices, which occupy about 80% of the market. Static Var Generator (SVG) only applies more in wind power, steel, metallurgy, rail transit, and its application in power grid is still in the pilot stage, having not formed a large market scale but with great market potential.
To Get Download Full Report With TOC: http://www.marketresearchreports.biz/sample/sample/189185
With the gradual maturity and improvement of SVC and SVG technology, the product costs have been dropping, the application field will continue to expand, and the market share will also increase, while the market share of shunt capacitor reactive power compensation device will decline.
Under current conditions, the actual demand for SVC products occupies about 30% of the total demand for reactive power compensation devices. In the next decade, due to the increase in installed capacity, the annual average demand for reactive power compensation products from the power industry will exceed 96 million kvar, and the annual average demand for SVC products will remain over 28.8 million kvar.
MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.
90 Sate Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-997-4948